GB2012164A - Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts - Google Patents

Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts

Info

Publication number
GB2012164A
GB2012164A GB7835594A GB7835594A GB2012164A GB 2012164 A GB2012164 A GB 2012164A GB 7835594 A GB7835594 A GB 7835594A GB 7835594 A GB7835594 A GB 7835594A GB 2012164 A GB2012164 A GB 2012164A
Authority
GB
United Kingdom
Prior art keywords
8beta
carbonyloxymethyl
perhydroazepinyl
ergoline
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7835594A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siphar SA
Original Assignee
Siphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar SA filed Critical Siphar SA
Publication of GB2012164A publication Critical patent/GB2012164A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Disorders of psychogenic origin are treated with a composition containing D-2-bromo-1,6-dimethyl- 8beta-(perhydroazepinyl-carbonyloxymethyl) ergoline as such or salified in a pharmaceutically acceptable form. <IMAGE>
GB7835594A 1978-01-17 1978-09-05 Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts Withdrawn GB2012164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH48378A CH632162A5 (en) 1978-01-17 1978-01-17 PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF DISORDERS OF PSYCHOGENIC ORIGIN.

Publications (1)

Publication Number Publication Date
GB2012164A true GB2012164A (en) 1979-07-25

Family

ID=4188032

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7835594A Withdrawn GB2012164A (en) 1978-01-17 1978-09-05 Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts

Country Status (5)

Country Link
JP (1) JPS54100395A (en)
BE (1) BE870487R (en)
CH (1) CH632162A5 (en)
FR (1) FR2414334A2 (en)
GB (1) GB2012164A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619709A5 (en) * 1975-03-14 1980-10-15 Siphar Sa Process for the preparation of carbamates of 2-halogenoergolines and 2-halogenoergolenes

Also Published As

Publication number Publication date
CH632162A5 (en) 1982-09-30
FR2414334A2 (en) 1979-08-10
BE870487R (en) 1979-01-02
JPS54100395A (en) 1979-08-08

Similar Documents

Publication Publication Date Title
IL98163A0 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides,pharmaceuticals containing these compounds and their use
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
EP0103796A3 (en) Dihydropyrimidines, process for their preparation and their use in medicaments
JPS5251327A (en) 3-trihydroxygermylpropionic acid and its salts and process for prepari ng the same
YU159475A (en) Process for obtaining new benzimidazoline derivatives
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
ES8304976A1 (en) Tryptamine derivatives of thienyloxypropanol amines, process for their preparation, pharmaceutical compositions containing them and preparation of the latter.
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
JPS5251755A (en) Agents for treating excreta
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
GB2012164A (en) Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts
JPS52250A (en) Process for preparation of 8-exo-hydroxy-endo-tricyclo-(5,2,2,02,6) ) unde cane
GR3003656T3 (en)
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.
PT91610A (en) PROCESS FOR THE PREPARATION OF COMPOUNDS FOR THE TREATMENT OF RHEUMATOIDAL ARTERITIS
JPS5241193A (en) Treating process of active carbon having not property reducing nitroge n dioxide
JPS51144390A (en) Stable viscosity-increasing agents for inorganic acids
JPS51149787A (en) X-ray mashine for dental surgery
JPS5264697A (en) Process for treating single area
JPS51128474A (en) Process for treating of microbial cells
JPS524854A (en) Objective=lens used for microscope
JPS52102431A (en) Remedies for mental disorder

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)